Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:34944522

Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases.

Ramilia Vlasenkova · Alsina Nurgalieva · Natalia Akberova · Mikhail Bogdanov · Ramziya Kiyamova

Biomolecules · 2021 doi:10.3390/biom11121878

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:34944522
kind
science-record
content_hash
sha256:e5bee1b667266d691ab825d1f8e8ce67372ee8780bde4e3bc55ad03da45b800c
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T17:36:39Z
updated_at
2026-11-01T22:48:06Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases.
doi
10.3390/biom11121878
pmid
34944522
authors array · 5 items
[0]
Ramilia Vlasenkova
[1]
Alsina Nurgalieva
[2]
Natalia Akberova
[3]
Mikhail Bogdanov
[4]
Ramziya Kiyamova
journal
Biomolecules
year
2021
abstract
The main goal of this study is to consider SLC34A2 as a potential prognostic marker of oncological diseases using the mutational, expression, and survival data of cancer studies which are publicly available online. We collected data from four databases (cBioPortal, The Cancer Genome Atlas; cBioPortal, Genie; International Cancer Genome Consortium; ArrayExpress). In total, 111,283 samples were categorized according to 27 tumor locations. Ninety-nine functionally significant missense mutations and twelve functionally significant indel mutations in SLC34A2 were found. The most frequent mutations were SLC34A2-ROS1, p.T154A, p.P506S/R/L, p.G257A/E/R, p.S318W, p.A396T, p.P410L/S/H, p.S461C, p.A473T/V, and p.Y503H/C/F. The upregulation of SLC34A2 was found in samples of myeloid, bowel, ovarian, and uterine tumors; downregulation was found in tumor samples of breast, liver, lung, and skin cancer tumors. It was found that the life expectancy of breast and thymus cancer patients with an SLC34A2 mutation is lower, and it was revealed that SLC34A2 overexpression reduced the life span of patients with brain, ovarian, and pancreatic tumors. Thereby, for these types of oncological diseases, the mutational profile of SLC34A2 can be a potential prognostic marker for breast and thymus cancers, and the upregulation of SLC34A2 can be a potential prognostic marker for brain, ovarian, and pancreatic cancers.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples. A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05). For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05).
kind
methodological
target
null
evidence array · 3 items
[0] object · 3 fields
asset
source:pmid:34944522
locator
sections[5] "2.3. Analysis of the Expression Levels in Various Tumors" paragraph 2
quote
A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples.
[1] object · 3 fields
asset
source:pmid:34944522
locator
sections[6] "2.4. Survival Analysis" paragraph 2
quote
A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05).
[2] object · 3 fields
asset
source:pmid:34944522
locator
sections[6] "2.4. Survival Analysis" paragraph 3
quote
For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05).
state
complete
[1] object · 6 fields
id
claim-data-access
statement
Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34944522
locator
sections[19] "notes" paragraph 1
quote
Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
SLC34A2 mutations were associated with lower life expectancy in breast and thymus cancer, while SLC34A2 overexpression was associated with shorter survival in brain, ovarian, and pancreatic tumors.
kind
qualitative
target
null
evidence array · 2 items
[0] object · 3 fields
asset
source:pmid:34944522
locator
sections[10] "3.3. Characterization of the SLC34A2 Gene as a Prognostic Marker" paragraph 3
quote
The life expectancy of patients with mutations in the SLC34A2 gene is significantly lower than in patients without gene alterations in studies of breast (p < 0.042) and thymus (p < 0.0008) tumors (cBioPortal, TCGA: Breast invasive carcinoma, n = 1082, Thymoma, n = 122; Figure 3A-B).
[1] object · 3 fields
asset
source:pmid:34944522
locator
sections[10] "3.3. Characterization of the SLC34A2 Gene as a Prognostic Marker" paragraph 4
quote
The life expectancy of patients with a high expression of SLC34A2 is significantly lower than that of patients with a lower expression of the gene in studies of brain (p < 0.043), ovarian (p < 0.0031), and pancreatic (p < 0.0015) cancer (cBioPortal, TCGA: Brain Lower Grade Glioma, n = 514, Glioblastoma multiforme, n = 592, Ovarian serous cystadenocarcinoma—n = 299, Pancreatic adenocarcinoma, n = 179, p < 0.05; Figure 3C–E).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
SLC34A2 mutations were associated with lower life expectancy in breast and thymus cancer, while SLC34A2 overexpression was associated with shorter survival in brain, ovarian, and pancreatic tumors.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:34944522
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:E-MTAB-3732
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:group_comparison_wilcoxon
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:E-MTAB-3732
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:run_analysis blocked on method:group_comparison_wilcoxon
data object · 3 fields
state
partial
assets array · 2 items
[0] object · 15 fields
id
source:pmid:34944522
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3390/biom11121878
sha256
sha256:f1dfc55592d1e3b1a641d1b1a2672f56b2e710765a0943b40fb5d4bbba5cde89
bytes
22960
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3390/biom11121878
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8699446
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:E-MTAB-3732
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=E-MTAB-3732
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
E-MTAB-3732
version
null
note
Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
null
resolution_checked_at
2026-11-01T17:30:51Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 2 items
[0]
asset:data:geo:E-MTAB-3732 not downloaded
[1]
asset:data:geo:E-MTAB-3732 licence not read
analysis object · 4 fields
state
partial
methods array · 2 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
wilcoxon
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
reordered
quote
A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples. A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05). For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05).
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
Cox regression
targets array · 0 items
gaps array · 1 item
[0]
method.group_comparison_wilcoxon
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
E-MTAB-3732
resolved_accessions array · 1 item
[0]
E-MTAB-3732
statements array · 1 item
[0]
Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.
basis
The paper names E-MTAB-3732 in ArrayExpress and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:34944522
[1]
data:geo:E-MTAB-3732
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
group_comparison_wilcoxon
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:E-MTAB-3732
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T17:12:49Z
independence
single_reader
evidence_check object · 2 fields
method
reordered
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
7756
completion_tokens
2400
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:34944522
type
paper
label
pmid:34944522
[1] object · 3 fields
id
source:pmid:34944522
type
manuscript
label
PMID 34944522 full text
[2] object · 3 fields
id
data:geo:E-MTAB-3732
type
dataset
label
GEO E-MTAB-3732
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:34944522
type
paper
label
pmid:34944522
[1] object · 3 fields
id
source:pmid:34944522
type
manuscript
label
PMID 34944522 full text
[2] object · 3 fields
id
data:geo:E-MTAB-3732
type
dataset
label
GEO E-MTAB-3732
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-34944522
type
extraction
used array · 1 item
[0]
source:pmid:34944522
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-E-MTAB-3732
type
accession_resolution
used array · 1 item
[0]
data:geo:E-MTAB-3732
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:34944522
parent_hash
sha256:6128433232e052ef6cbc159e354f8ff2928cf240effde2d40e30ecf5b5aae495
fork_of
null
gaps array · 8 items
[0]
asset:data:geo:E-MTAB-3732 licence not read
[1]
asset:data:geo:E-MTAB-3732 not downloaded
[2]
execution.not_run
[3]
method.group_comparison_wilcoxon
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
[7]
step:run_analysis blocked on method:group_comparison_wilcoxon
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples. A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05). For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05).
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34944522", "kind": "science-record", "revision": 5, "content_hash": "sha256:e5bee1b667266d691ab825d1f8e8ce67372ee8780bde4e3bc55ad03da45b800c", "created_at": "2026-11-01T17:36:39Z", "updated_at": "2026-11-01T22:48:06Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases.", "doi": "10.3390/biom11121878", "pmid": "34944522", "authors": ["Ramilia Vlasenkova", "Alsina Nurgalieva", "Natalia Akberova", "Mikhail Bogdanov", "Ramziya Kiyamova"], "journal": "Biomolecules", "year": 2021, "abstract": "The main goal of this study is to consider SLC34A2 as a potential prognostic marker of oncological diseases using the mutational, expression, and survival data of cancer studies which are publicly available online. We collected data from four databases (cBioPortal, The Cancer Genome Atlas; cBioPortal, Genie; International Cancer Genome Consortium; ArrayExpress). In total, 111,283 samples were categorized according to 27 tumor locations. Ninety-nine functionally significant missense mutations and twelve functionally significant indel mutations in SLC34A2 were found. The most frequent mutations were SLC34A2-ROS1, p.T154A, p.P506S/R/L, p.G257A/E/R, p.S318W, p.A396T, p.P410L/S/H, p.S461C, p.A473T/V, and p.Y503H/C/F. The upregulation of SLC34A2 was found in samples of myeloid, bowel, ovarian, and uterine tumors; downregulation was found in tumor samples of breast, liver, lung, and skin cancer tumors. It was found that the life expectancy of breast and thymus cancer patients with an SLC34A2 mutation is lower, and it was revealed that SLC34A2 overexpression reduced the life span of patients with brain, ovarian, and pancreatic tumors. Thereby, for these types of oncological diseases, the mutational profile of SLC34A2 can be a potential prognostic marker for breast and thymus cancers, and the upregulation of SLC34A2 can be a potential prognostic marker for brain, ovarian, and pancreatic cancers.", "claims": [{"id": "claim-method", "statement": "A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples. A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05). For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34944522", "locator": "sections[5] \"2.3. Analysis of the Expression Levels in Various Tumors\" paragraph 2", "quote": "A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples."}, {"asset": "source:pmid:34944522", "locator": "sections[6] \"2.4. Survival Analysis\" paragraph 2", "quote": "A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05)."}, {"asset": "source:pmid:34944522", "locator": "sections[6] \"2.4. Survival Analysis\" paragraph 3", "quote": "For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34944522", "locator": "sections[19] \"notes\" paragraph 1", "quote": "Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732."}], "state": "complete"}, {"id": "claim-target-result", "statement": "SLC34A2 mutations were associated with lower life expectancy in breast and thymus cancer, while SLC34A2 overexpression was associated with shorter survival in brain, ovarian, and pancreatic tumors.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:34944522", "locator": "sections[10] \"3.3. Characterization of the SLC34A2 Gene as a Prognostic Marker\" paragraph 3", "quote": "The life expectancy of patients with mutations in the SLC34A2 gene is significantly lower than in patients without gene alterations in studies of breast (p < 0.042) and thymus (p < 0.0008) tumors (cBioPortal, TCGA: Breast invasive carcinoma, n = 1082, Thymoma, n = 122; Figure 3A-B)."}, {"asset": "source:pmid:34944522", "locator": "sections[10] \"3.3. Characterization of the SLC34A2 Gene as a Prognostic Marker\" paragraph 4", "quote": "The life expectancy of patients with a high expression of SLC34A2 is significantly lower than that of patients with a lower expression of the gene in studies of brain (p < 0.043), ovarian (p < 0.0031), and pancreatic (p < 0.0015) cancer (cBioPortal, TCGA: Brain Lower Grade Glioma, n = 514, Glioblastoma multiforme, n = 592, Ovarian serous cystadenocarcinoma—n = 299, Pancreatic adenocarcinoma, n = 179, p < 0.05; Figure 3C–E)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "SLC34A2 mutations were associated with lower life expectancy in breast and thymus cancer, while SLC34A2 overexpression was associated with shorter survival in brain, ovarian, and pancreatic tumors.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34944522"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:E-MTAB-3732"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:group_comparison_wilcoxon", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:E-MTAB-3732"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:group_comparison_wilcoxon"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34944522", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3390/biom11121878", "sha256": "sha256:f1dfc55592d1e3b1a641d1b1a2672f56b2e710765a0943b40fb5d4bbba5cde89", "bytes": 22960, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3390/biom11121878", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8699446", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:E-MTAB-3732", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=E-MTAB-3732", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "E-MTAB-3732", "version": null, "note": "Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": null, "resolution_checked_at": "2026-11-01T17:30:51Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:E-MTAB-3732 not downloaded", "asset:data:geo:E-MTAB-3732 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "reordered", "quote": "A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples. A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05). For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05)."}}, {"id": "method-2", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Cox regression"}}], "targets": [], "gaps": ["method.group_comparison_wilcoxon"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["E-MTAB-3732"], "resolved_accessions": ["E-MTAB-3732"], "statements": ["Publicly available datasets were analyzed in this study. These datasets can be found here (the data was downloaded on 21 December 2020): http://www.cbioportal.org, https://genie.cbioportal.org/, https://dcc.icgc.org/, and https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-3732."], "basis": "The paper names E-MTAB-3732 in ArrayExpress and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:34944522", "data:geo:E-MTAB-3732"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "group_comparison_wilcoxon", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:E-MTAB-3732"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:12:49Z", "independence": "single_reader"}, "evidence_check": {"method": "reordered", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 7756, "completion_tokens": 2400, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34944522", "type": "paper", "label": "pmid:34944522"}, {"id": "source:pmid:34944522", "type": "manuscript", "label": "PMID 34944522 full text"}, {"id": "data:geo:E-MTAB-3732", "type": "dataset", "label": "GEO E-MTAB-3732"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34944522", "type": "paper", "label": "pmid:34944522"}, {"id": "source:pmid:34944522", "type": "manuscript", "label": "PMID 34944522 full text"}, {"id": "data:geo:E-MTAB-3732", "type": "dataset", "label": "GEO E-MTAB-3732"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34944522", "type": "extraction", "used": ["source:pmid:34944522"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-E-MTAB-3732", "type": "accession_resolution", "used": ["data:geo:E-MTAB-3732"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34944522", "parent_hash": "sha256:6128433232e052ef6cbc159e354f8ff2928cf240effde2d40e30ecf5b5aae495", "fork_of": null, "generation": 4}, "gaps": ["asset:data:geo:E-MTAB-3732 licence not read", "asset:data:geo:E-MTAB-3732 not downloaded", "execution.not_run", "method.group_comparison_wilcoxon", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:run_analysis blocked on method:group_comparison_wilcoxon"], "assays": [{"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["A Wilcoxon test (p < 0.05) was performed in order to compare healthy and tumor samples. A survival analysis was performed using the Kaplan–Meyer estimate (p < 0.05). For each study in which we found significant differences between the patient groups by the Kaplan–Meyer estimate, multivariate survival analysis was performed using Cox regression (p < 0.05)."], "order_basis": "analysis_only", "id": "assay:1"}]}